Nortis
Woodinville
About Nortis
Nortis is a biotech company that has developed tissue-engineering techniques and organ-on-a-chip systems for the creation of a human micro-tissue environment within small, disposable, microfluidic chips. The company's technology enables living models of human organs that will drastically accelerate the discovery and introduction of new therapies and alleviate the use of lab animals. By growing tissue from human organ systems inside small microfluidic chips, researchers and assay developers can conduct in-vitro testing directly on functional human tissues. Nortis was founded in 2012 and is headquartered in Woodinville, Washington.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.3M
- Last round: Series Unknown (Aug 2022)
- Website: nortisbio.com
- Phone: 425-486-4777
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/nortis-2387 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.